US 12,324,926 B2
Device and method for eradicating pathogens in nasal passages
Christopher R. Brown, Greensburg, IN (US); and Mark T. Volz, Batesville, IN (US)
Assigned to Neuraxis, Inc., Versailles, IN (US)
Filed by Neuraxis, Inc., Versailles, IN (US)
Filed on Jun. 2, 2022, as Appl. No. 17/830,411.
Claims priority of provisional application 63/197,609, filed on Jun. 7, 2021.
Prior Publication US 2022/0387817 A1, Dec. 8, 2022
Int. Cl. A61N 5/06 (2006.01)
CPC A61N 5/0603 (2013.01) [A61N 5/0624 (2013.01); A61N 2005/0607 (2013.01); A61N 2005/0626 (2013.01); A61N 2005/0632 (2013.01); A61N 2005/0652 (2013.01); A61N 2005/0663 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A device for eradicating at least one pathogen in a nasal passage of a human or animal, the device comprising:
a housing configured to be inserted into the nasal passage,
at least one radiation source, configured to emit radiation, coupled to the housing such that at least a portion of a radiation emitting surface of the at least one radiation source, upon insertion of the housing into the nasal passage, faces at least a portion of nasal lining of the nasal passage, and
an electrical circuit carried by the housing and electrically connected to the at least one radiation source, the electrical circuit including at least one circuit component for controlling the at least one radiation source to emit the radiation to irradiate the nasal passage, the emitted radiation having a frequency or range of frequencies at which the at least one pathogen in the nasal passage, when irradiated by the emitted radiation, is eradicated.